Emerging studies indicate an association between virus-induced impairment in type I interferon (IFN-I) production and enhanced susceptibility to opportunistic infections, which represent a major health problem. Here, we provide in vivo evidence that lymphocytic choriomeningitis virus (LCMV) infection of its natural murine host dramatically diminishes the unique capacity of plasmacytoid dendritic cells (pDCs) to secrete high levels of systemic IFN-I. While both acute and persistent LCMV infections suppress pDC IFN-I response, only the persistent virus induces a long-lasting diversion of this innate immune pathway. The consequent reduction in IFN-I production serves to impair natural killer cell responses in LCMV-infected mice challenged subsequently with murine cytomegalovirus (MCMV) as an opportunistic pathogen. This innate defect also compromises the host's ability to counteract early MCMV spread. These findings provide a mechanistic explanation for the occurrence of opportunistic infections following viral insults and have important implications for treating such medical complications.
INTRODUCTION
Virus infections are often associated with a transient or longlasting generalized suppression of the host immune response. Dramatic examples of the global impact of virus-induced immunosuppression are the 40 million individuals infected worldwide with human immunodeficiency virus type-1 (HIV-1) with more than 3 million deaths per year, mainly as a result of opportunistic secondary infections (Mathers and Loncar, 2006) . Similarly, measles virus (MV) that currently infects over 30 million individuals worldwide leads to approximately 500,000 deaths annually also primarily as a consequence of secondary infections (Griffin, 1995; Guilbert, 2003) . Both of these infections illustrate the clinical relevance of virus-induced immunosuppression and the importance of a healthy immune system to ward off infections with opportunistic pathogens. In addition to the well-established contribution of altered adaptive immunity to viral-induced immunosuppression (Chisari and Ferrari, 1995; Klenerman and Hill, 2005; Oldstone, 2006; Shoukry et al., 2004; Wherry and Ahmed, 2004) , in vitro and epidemiological evidences indicate an association between defective production of type I interferons (IFN-I) and more frequent opportunistic infections (Hosmalin and Lebon, 2006; Schlender et al., 2005; Siegal, 2003; Siegal et al., 2001) .
IFN-I orchestrate numerous biological and cellular processes and are a critical link between innate and adaptive immunity (Garcia-Sastre and Le Bon and Tough, 2002) . Although any cell can potentially produce IFN-I upon virus infection, plasmacytoid DCs (pDCs), also known as IFN-producing cells, are a unique cell type specialized to rapidly produce prodigious amount of these innate mediators following infection by multiple viruses Colonna et al., 2004; Kadowaki and Liu, 2002; Le Bon and Tough, 2002; Liu, 2005; McKenna et al., 2005) . Indeed, pDCs dedicate 50% of their transcription to make IFN-I mRNA and following viral stimulation synthesize a significantly broad range of these closely related cytokines including IFN-a, IFN-b, IFN-u, IFN-l, and IFN-t, in some cases without requiring viral replication (Lee et al., 2007; Liu, 2005) . Through the secretion of such important innate factors, pDCs orchestrate a systemic antiviral state programmed to directly control viral growth and communicate danger signals to other innate cells such as natural killer (NK) cells (McKenna et al., 2005) . To accomplish this key role, pDCs use the Toll-like receptor (TLR) system (Kato et al., 2006) , including TLR-7 (Diebold et al., 2004; Heil et al., 2004; Lund et al., 2004) and TLR-9 (Bauer et al., 2001; Jarrossay et al., 2001; Kadowaki et al., 2001; Krug et al., 2001; Lund et al., 2003) , which rapidly trigger IFN-I transcription through a MyD88-dependent signaling pathway. TLR-9 mediates recognition of CpG-rich regions in the genome of DNA viruses and bacteria including herpes simplex virus 1 and 2, murine cytomegalovirus (MCMV) (Delale et al., 2005) , and mycobaterium tuberculosis (Bafica et al., 2005) . TLR-9 also senses malaria pigment hemozoin, extending its role to host defense against parasite infections (Coban et al., 2005) . On the other hand, TLR-7 recognizes single stranded (ss)RNA viruses such as HIV, influenza, and vesicular stomatitis virus (VSV) through the binding of uridine and guanosine rich sequences (Diebold et al., 2004; Heil et al., 2004; Lund et al., 2004) . pDCs produce most of the IFN-a protein within the first 24 hr following viral stimulation and then differentiate into mature DCs with enhanced antigen presenting capacity (Liu, 2005) . In vitro studies indicated that after the first wave of IFN-I production, pDCs are refractory upon secondary stimulations to produce these cytokines (Jarrossay et al., 2001) . However, how these observations translate into an in vivo acute and persistent viral infection in terms of systemic IFN-I production, innate response, and susceptibility to secondary opportunistic infections is unclear.
In the present report we use lymphocytic choriomeningitis virus (LCMV) infection in its natural host, the mouse, to investigate the ability of pDCs from acutely or persistently infected hosts to produce systemic IFN-I during in vivo challenge with TLR ligands. We examine how this response is associated with pDC numbers and functional status. Finally, we evaluate the biological significance of virus-altered pDC-IFN-I production in the context of opportunistic infections in terms of systemic IFN-I levels, activation and function of NK cells, and early innate control of the secondary pathogen.
RESULTS

Rapid Silencing of Systemic IFN-I Production during Both Acute and Persistent Viral Infections
To gain insight on systemic IFN-I regulation during acute and persistent viral infections, we analyzed sera IFN-I levels throughout the course of LCMV infection. LCMV Armstrong 53b (ARM) and Clone 13 (Cl 13) isolates were used to model in vivo acute and persistent infection, respectively (Ahmed et al., 1984) , and the levels of IFN-I were determined in sera ( Figure 1A , left axis). ARM and Cl 13-infected mice exhibited comparable kinetics of systemic IFN-I in sera, which peaked at day 1 after inoculation. By 5 days postinfection (pi), systemic levels of IFN-I returned to baseline and remained undetectable throughout the course of the infection regardless of whether viral clearance (ARM) or persistence (Cl 13) occurred. These data indicate that even in the presence of persistent Cl 13 replication of 1 3 10 4 to 1 3 10 6 PFU/ml in blood and several tissues (Ahmed et al., 1984; Moskophidis and Zinkernagel, 1995) , the initial wave of systemic IFN-I is silenced. This observation suggested that LCMV infection was deregulating innate immunity and raised the dual issue of the host ability to reinduce IFN-I systemically at latter times, and what the biological impact of IFN-I silencing would be upon subsequent stimulations or infections.
Differential Deregulation of TLR-Induced IFN-I Production during LCMV Infection TLRs are well-characterized pattern recognition receptors that induce IFN-I in response to microbial stimulation (Akira, 2006; Beutler et al., 2006; Janeway and Medzhitov, 2002) . We investigated whether acute and/or persistent LCMV infection impacted the ability of the host to increase systemic IFN-I levels in response to TLR challenges. We focused on TLR-9 and TLR-4 stimulation as representative MyD88-dependent and -independent pathways of IFN-I induction, respectively (Akira, 2006; O'Neill, 2006) . Uninfected and ARM (acute) and Cl 13 (persistent) -infected mice at day 5 and 30 pi were injected with CpG-ODN (TLR-9 ligand) or lypopolysaccharide (LPS, TLR-4 ligand). The levels of IFN-I were determined in sera by luciferase bioassay (Jiang et al., 2005) (Figures 1B and 1D ). As previously reported uninfected mice rapidly responded to CpG challenge by elevating systemic IFN-I levels in sera displaying a peak response at about 3.5 hr poststimulation (Figure 1B) . In contrast, following inoculation of CpG at day 5 pi, both ARM-and Cl 13 -infected mice presented a dramatic reduction in IFN-I levels when compared to uninfected controls. The inhibited IFN-I response was transient for ARM-infected mice but long-term for Cl 13-infected mice since such mice still failed to respond to CpG at 30 and 40 days pi when LCMV-ARM-infected mice had returned to normal ( Figure 1B and data not shown). Similar results were obtained when IFN-a was quantified by ELISA at day 5 after ARM infection ( Figure 1C) . Importantly, the defective IFN-I production during LCMV infection was not due to an enhanced degradation of the administered CpG or a general failure to respond to TLR-9, since upon CpG injection LCMV-infected mice produced higher levels of IFN-g compared to uninfected controls and succumbed to death within 24 and 48 hr after TLR-9 stimulation ( Figure S1 and data not shown). As reported before, minimal amounts of IFN-I were detected in uninfected mouse sera after in vivo administration of LPS (Asselin-Paturel et al., 2005) ( Figure 1D ). In sharp contrast to the TLR-9 response, IFN-I was overproduced in response to LPS in mice infected with ARM at day 5 pi and Cl 13 at day 5 and 30 pi, inducing lethality between 6.5 and 24 hr after stimulation ( Figure 1D and data not shown). These results were confirmed by quantification of IFN-a by Elisa at day 5 after ARM infection ( Figure 1E ). Finally, we tested the ability of uninfected and ARM-infected mice to enhance systemic IFN-I upon stimulation with the TLR-3 ligand polyribocytidylic acid, (poly[I:C], Figure S2 ). We found profound reduction in TLR3-induced IFN-I levels in LCMV-infected mice compared to uninfected controls.
Altogether, these data indicate that during in vivo virus infection, the ability of the innate immune system to produce IFN-I upon discrete TLR stimulations can be differentially modulated. Specifically during LCMV infection, TLR-9 and TLR-3 IFN-I responses are abrogated while TLR-4 signaling is enhanced. Moreover, while acute and persistent LCMV infection deregulate TLR-IFN-I response, only the persistent infection induces a longlasting diversion of these innate pathways.
Quantitative and Qualitative Defects of pDCs during Acute and Persistent LCMV Infection pDCs are responsible for the production of IFN-I upon CpG-ODN administration . We next investigated whether the affected TLR-9 IFN-I secretion during in vivo LCMV infection was due to a quantitative or qualitative defect on pDCs, or both. To address this question, we first assessed the percentage and numbers of pDCs in spleens from uninfected and ARM-and Cl 13-infected mice at day 5 and 30 pi (Figures 2A and 2B, respectively) . Both ARM and Cl 13 infection induced a significant reduction in pDC percentages and numbers at day 5 pi. However, by day 30 pi pDCs showed complete recovery in ARM infected mice, but Cl 13-infected mice still exhibited a decreased number of these cells. Earlier we reported a reduced number of pDCs in the bone marrow of LCMV infected mice (Zuniga et al., 2004) . These data indicate that LCMV infection affects the availability of pDCs in primary and secondary lymphoid organs and suggest that this likely contributes to the suppressed production of IFN-I observed in vivo. However, the altered pDC numbers did not completely account for the profound suppression of IFN-I production in LCMV-infected mice upon in vivo CpG challenge. At day 30 pi pDCs were only $50% reduced while CpG-induced IFN-I levels in Cl 13-infected mice were almost undetectable. This led to the next series of studies to examine the functional capacity of the remaining pDCs to produce IFN-I upon CpG stimulation. pDCs from uninfected or ARM-or Cl 13-infected mice were purified at day 5 and 30 pi and cultured in the absence or in the presence of two different CpG sequences that normally induce significant IFN-I production by mouse pDCs Boonstra et al., 2003; Gilliet et al., 2002; Figures 2C and 2D) . In accordance with the in vivo data, production of IFN-I in response to CpGODNs was significantly impaired in pDCs from day 5 ARMand Cl 13-infected mice as compared to uninfected controls ( Figure 2C ). At day 30 pi only pDCs from Cl 13-infected mice displayed lower IFN-I production in response to CpG challenge ( Figure 2D ), indicating a long-lasting pDC intrinsic defect during persistent LCMV infection. Remarkably, pDCs from ARM-and Cl (A-E) Mice were infected with ARM or Cl 13 LCMV. Eye-bleed samples were collected before infection (day 0) and at 1, 3, 5, 30, and 40 days p.i. IFN-I activity was measured by luciferase bioassay (left y axis) and LCMV titer by plaque assay (right y axis). Uninfected ARM-and Cl 13-infected mice at day 5 or 30 p.i. were injected with CpG (B-C) or LPS (D-E). Blood samples were collected before injection (0 hr) and at 3.5, 6.5, and 12 hr poststimulation. IFN-I activity was measured by luciferase bioassay and the fold of increase respect to levels at 0 hr is shown (B and D). ELISA was used to quantify IFN-a in samples collected at 3.5 hr after stimulation from day 5 ARM-infected mice (C and E). The mean ± SD obtained with three to four mice per group is shown (*LCMV-infected compared to uninfected group p < 0.01). Data are representative of two to eight independent experiments. 13-infected mice also failed to produce IFN-I upon TLR-7 stimulation at day 5 pi and continued to be suppressed for 30 days after Cl 13, but not ARM, infection ( Figure S3 ). To further investigate the pDC functional status during LCMV infection, we analyzed the ability of pDCs to respond to TLR signaling by producing TNF-a, IL-12, RANTES, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1a (MIP-1a) and expressing MHC class II and B7-2 molecules ( Figure 3) . Strikingly, the production of the aforementioned cytokines and chemokines were not impeded by LCMV ARM or Cl 13 infection. The expression of MHC class II molecule was also comparable among pDCs from uninfected and LCMV-infected mice upon CPG stimulation while B7-2 expression was upregulated in pDCs from infected mice. Importantly, the levels of IFN-I in the same cell culture supernatant were dramatically reduced, consistently with the results described in Figure 2C . These data indicate that LCMV infection selectively alters the most unique function of pDCs without affecting their more redundant functional properties.
In Toto, these results indicate that both acute and persistent in vivo LCMV infection disable a fundamental pillar of immunity not only by dampening the amount of pDCs available for innate response but also interfering with their unique capacity to massively produce IFN-I upon TLR stimulation.
IFN-IR, IL-10, IFN-g, TNF-a, and T Cells Are Dispensable for TLR9-IFN-I Impairment during LCMV Infection Since the inhibition of TLR IFN-I production by pDCs occurs to similar extends during ARM (minimal DC infection) and Cl 13 (robust replication in DCs) infections, it is likely that this alteration is at least in part consequence of pDC exposure to the infectious environment. In a search for a factor responsible for TLR-9-IFN-I inhibition during LCMV infection, we analyzed the participation of elements with demonstrated ability to suppress IFN-I production and or pDC responses (Duramad et al., 2003; Fallarino et al., 2005; Gary-Gouy et al., 2002; Palucka et al., 2005) . For that, we injected CPG in IFN-I receptor (R) knockout (ko), IL-10 ko, IFN-g ko, TNF-a ko, and T cell-deficient TCR ko mice infected with ARM and compared their systemic IFN-I response to WT-infected and -uninfected controls ( Figures 4A-4E , respectively). We found similar degree of IFN-I suppression in the aforementioned ko infected mice compared to their WT counterparts, indicating that neither IFN-I negative feedback, IL-10, IFN-g, TNF-a, T cells, or T cell-derived factors are essential for inhibition of TLR9-IFN-I production during ARM infection. We also investigated the participation of IFN-I and IL-10 in systemic IFN-I suppression upon CPG stimulation during the chronic phase of Cl 13 infection by using IFN-IR ko mice or by administering anti-IL10R mAb at day 20 pi. Again, both of these settings showed no restoration of IFN-I production (data not shown).
Although the molecular factors underlying IFN-I suppression during LCMV infection are yet to be identified, these data illuminate the complexity and uniqueness of TLR-IFN-I inhibition during viral infection and pose a challenge for future investigations.
Defective IFN-I Response during Secondary Infections with Unrelated Pathogens TLR-9 plays a critical role for host defense against multiple microbes including DNA viruses and mycobacteria (Bafica et al., 2005; Coban et al., 2005; Delale et al., 2005; Krug et al., 2004; Tabeta et al., 2004) . Thus, the impact of the long-term inhibition of TLR-9 IFN-I production during Cl 13 infection on the innate response to an opportunistic pathogen was evaluated. We used murine cytomegalovirus (MCMV) as a model opportunistic infection since initial IFN-I production 36 hr after MCMV infection is known to be pDC-TLR-9 dependent (Asselin-Paturel et al. MCMV and systemic levels of IFN-I determined ( Figure 5A ). As anticipated (Orange and Biron, 1996) , control mice that received a primary infection with MCMV triggered a robust IFN-I secretion in sera as compared to uninfected mice. In contrast, a profound reduction of IFN-I was observed in Cl 13-infected mice receiving MCMV. Next, IFN-I production by splenic pDCs from controls or Cl 13-infected mice challenged with MCMV was determined ( Figure 5B ). While, pDCs from control MCMV-infected mice produced high levels of IFN-I, their counterparts from Cl 13-MCMV coinfected mice failed to enhance IFN-I levels. These findings indicate that LCMV infection disrupts pDC IFN-I secretion in response to in vivo MCMV challenge. To further examine the extend of IFN-I alteration during chronic LCMV infection, we tested IFN-I production in Cl 13-infected mice upon secondary infection with VSV ( Figure 5C ). We found that mice with a progressing Cl 13 infection also failed to elicit systemic IFN-I levels upon VSV secondary infection. This is consistent with the previously reported TLR-7-dependent IFN-I response during VSV infection (Lund et al., 2003) and the impaired TLR-7 IFN-I production by pDCs that we described in Figure S3 . We also investigated whether primary infection with MCMV compromises systemic IFN-I production upon LCMV secondary infection. We observed that an ongoing MCMV infection reduces systemic IFN-I response upon a subsequent infection with LCMV Cl 13 (Figure 5D ). These data support the idea that pDC-IFN-I inhibition is a general event during primary viral infections that prevents the systemic IFN-I elevation upon exposure to distinct opportunistic pathogens.
Impaired NK Cell Response in LCMV-Infected Mice upon Secondary MCMV Exposure
It has been demonstrated that during MCMV infection, production of IFN-I by pDCs is vital for NK cell activation and function (Dalod et al., 2003; Delale et al., 2005; Krug et al., 2004; Tabeta et al., 2004) . Therefore, we evaluated the NK cell response during persistent LCMV infection upon MCMV superinfection. We first determined the expression of the activation marker CD69 on NK cells from control or Cl 13-infected mice after MCMV infection ( Figures 6A and 6B ). Control mice showed both a higher percentage of CD69 + NK1.1 + CD3 À cells ( Figure 6A ) as well as an enhanced expression of CD69 ( Figure 6B ). Moreover, a significantly lower percentage of activated NK cells ( Figure 6A ) and a limited upregulation of CD69 upon MCMV infection was observed in Cl 13-MCMV dually infected mice compared to control-MCMV infected mice ( Figure 6B , black bars). To investigate NK cell functions during MCMV infection, IFN-g production and cytotoxicity by NK1.1 + CD3 À NK cells from control or Cl 13 infected was evaluated ( Figures 6C and 6D, respectively) . Results indicated a significant reduction in both IFN-g production and cytotoxic capacity of NK cells obtained from Cl , and TCR ko (E) mice at day 5 after ARM infection were injected with CPG. Uninfected and ARMinfected WT mice were processed in parallel as controls. Blood samples were collected at the indicated time points. Elisa was used to quantify IFN-a levels (A and B). IFN-I activity was measured by luciferase bioassay, and fold of increase respect to levels at 0 hr is shown (C-E). The mean ± SD obtained with three to four mice per group is shown (*LCMV-infected compared to uninfected group p < 0.01).
13-MCMV-coinfected mice compared to control MCMV-infected mice. Interestingly, NK cell dysfunction was accompanied with a significant reduction in systemic IFN-g levels after MCMV infection of Cl 13-infected mice compared to MCMV-infected controls ( Figure 6E ).
In concert, these results indicate that the long-term inhibition of TLR-9-IFN-I production during Cl 13 infection relates to impaired pDCs and NK cell innate responses upon subsequent encounter with an unrelated opportunistic pathogen.
Control of Early MCMV Replication Is Compromised in LCMV-Infected Mice
Early activation of pDCs and NK cells is decisive for counteracting MCMV spread (Dalod et al., 2003; Degli-Esposti and Smyth, 2005) . The next set of experiments investigates the biological impact of LCMV diversion of innate response on the containment of MCMV infection ( Figure 7A ). Control mice that received a primary infection with MCMV had less than 50 PFU/ml of MCMV by 4 days pi. In contrast, 3-4 log of infectious MCMV was detected in Cl 13-MCMV-coinfected mice. These results were further supported by real time PCR amplification of MCMV early inducible gene (Ie-1) ( Figure 7B) , showing a significantly higher expression in MCMV-Cl 13-infected mice compared to controls.
Different mechanisms are responsible in C57BL/6 mice for resistance against MCMV in the spleen (mostly NK cells) and in the liver (mainly IFN-g ). Therefore, we analyzed in parallel MCMV titers in spleens and livers ( Figure 7C ). The results indicate that while Cl 13-infected mice that received MCMV as a secondary infection exhibit $2 log higher MCMV titers in the spleen than controls, no significant differences could be detected in the liver. Considering the reduced IFN-g levels detected in the serum of LCMV-MCMV-coinfected mice ( Figure 6E ), it is likely that local secretion of IFN-g in the liver would compensate for its systemic deficit. We also investigated whether the failure to control MCMV secondary infection occurs during a primary acute infection with ARM, within the time window of altered pDC response ( Figure 7D ). As expected, the spleen MCMV titers were significantly elevated in LCMV-ARM-MCMV dual-infected mice compared to single MCMV-infected mice, but again, no increase could be appreciated in liver.
Finally, we evaluated early viral containment using different combinations of primary and secondary pathogens. We found that both control and Cl 13-infected mice that received VSV as primary and secondary infections, respectively, were able to completely eradicate the virus by day 4 pi (data not shown). Similarly, no differences in LCMV replication were detected when Cl 13 was used as a secondary pathogen to challenge mice with a progressing MCMV infection ( Figure 7E ).
These data indicate that the deleterious effect of LCMV infection on innate immune response(s) contributes to disarming the host capacity to contain early replication of an extraneous pathogen such as MCMV. However, the results obtained with VSV and LCMV secondary infections emphasize that the biological impact that IFN-I inhibition has on the early control of an opportunistic pathogen depends on the unique nature (i.e., viral properties, dose, route) of the secondary infection.
DISCUSSION
In vitro and epidemiological data support an association between increased incidence of opportunistic infections during HIV or MV infections and the inability of infected cells to produce IFN-I (Hosmalin and Lebon, 2006; Schlender et al., 2005; Siegal, 2001 Siegal, , 2003 . This report provides an explanation on how this impaired production of IFN-I contributes to pathogenesis in vivo. Compelling evidence show that in vivo infection with LCMV interferes with the unique ability of pDCs to secrete prodigious amount of IFN-I upon TLR stimulation. This innate immune deficiency is sustained over a long period during a persistent infection and is a direct consequence of quantitative and qualitative alterations on pDCs. Furthermore, this virally induced immune defect is biologically meaningful in preventing an effective innate response (i.e., systemic IFN-I production and NK cell function) by the host upon encountering an opportunistic pathogen, such as MCMV, and relates to early spread and delayed clearance of the secondary infection.
Like other viruses, LCMV induces enhanced systemic IFN-I early after infection (Biron, 1998) . At present the cellular source of the early wave of systemic IFN-I during LCMV infection is unclear. Although pDCs secrete IFN-I during LCMV infection (Jung et al., 2008; Montoya et al., 2005) , the early peak of systemic IFN-I was still detected in the absence of pDCs (Louten et al., 2006) . Importantly, systemic IFN-I is rapidly silenced during both acute and chronic LCMV infection, indicating that the production and presence of high viral load in blood and several tissues (Ahmed et al., 1984; Moskophidis and Zinkernagel, 1995) is not sufficient to maintain enhanced levels of IFN-I in serum. The inhibition of systemic IFN-I early after LCMV infection is in sharp contrast to the local IFN-I production by spleen and bone marrow DCs that support chronic infection by Cl 13 and manifest a sustained production of IFN-I for at least 50 days p.i. (Diebold et al., 2004; Hahm et al., 2005) . Thus, it is possible that LCMV has evolved selective strategies to block systemic IFN-I response and/or that the host is armed with immune-regulatory mechanisms to prevent sustained-systemic IFN-I production that could lead to immunopathology. Moreover, TLR-9 and TLR-3-IFN-I responses are dramatically abrogated during LCMV infection while, in contrast, TLR-4 signaling is enhanced. These observations demonstrate that an ongoing natural viral infection can differentially modulate the ability of the innate immune system to produce IFN-I upon in vivo TLR stimulation, specifically suppressing selective pathways while re-enforcing others. This differential deregulation may be applicable to other viral infections that, as LCMV (Doughty et al., 2001; Durbin et al., 2003; Nguyen and Biron, 1999) , induce an enhanced response to LPS and/or susceptibility to endotoxic shock (Baqui et LCMV infection affects pDCs at multiple levels. LCMV causes a numeric defect in this cell population in both periphery and bone marrow. This is likely related to the virus ability to block DC development from early undifferentiated progenitors (Hahm et al., 2005; Sevilla et al., 2004) and to redirect the differentiation of immature bone marrow pDCs into CD11b + cDCs (Zuniga et al., 2004) . In addition, LCMV infection alters the quality of the remaining pDCs by disabling their distinctive function (i.e., IFN-I production) without affecting secretion of other cytokines and maturation. The ability of LCMV or other viruses to selectively affect a unique function in neurons, endocrine cells, or immune cells while sparing other differentiated functions thereby disrupting homeostasis and causing disease has been previously reported (de la Torre et al., 1992 (de la Torre et al., , 1996 Oldstone, 1982 Oldstone, , 2002 . However, viral interference with IFN-I biosynthesis has been usually associated with virus replication within the affected cells, altering IFN-I induction, transcription, RNA processing, and/or translation (Garcia-Sastre and . In particular, LCMV infection of A549 cells inhibits IRF-3 phosphorylation and IFN-b synthesis (Martinez-Sobrido et al., 2006) . Strikingly, we found that at day 5 p.i., LCMV ARM suppresses pDC-IFN-I response to a similar extent than LCMV Cl 13, although the former one infects a minimal number of DCs while the latter one strongly replicate in this cell population (Borrow et al., 1995; Sevilla et al., 2000; data not shown) . These data suggest that virus replication within pDCs does not correlate with IFN-I inhibition but instead the pDC exposure to the infectious environment may play a major role. The pDC-IFN-I impairment could result from an advanced maturation status triggered by the virus infection and is consistent with a previous report demonstrating that DC exposure to herpes simplex virus in vivo, prevent them to produce IFN-a after rechallenge with the same virus in vitro (Bjorck, 2004) .
We investigated the biological implications of the impaired TLR-IFN-I response during LCMV infection by using MCMV as a model of opportunistic infections. MCMV is a well-characterized mouse natural pathogen (Krmpotic et al., 2003) , which is recognized by pDCs through TLR-9. As a result, a massive IFN-I response is initiated and is crucial for direct antiviral effect and the orchestration of other innate cells, i.e., NK cells (Biron, 1999; Dalod et al., 2003; Degli-Esposti and Smyth, 2005; Delale et al., 2005; Krug et al., 2004; Tabeta et al., 2004) . We noted that LCMV infection compromises MCMV and VSV innate responses as indicated by the reduced levels of systemic IFN-I. Moreover, also impaired IFN-g and defective activation and function of pDCs and NK cells were observed during superinfection of LCMV-infected mice with MCMV. NK cell dysfunction has been described previously during several viral infections (Ahmad and Alvarez, 2004; Fauci et al., 2005) , and our data suggest that their in vivo alteration could be in part a consequence of impaired TLR-IFN-I response. It is important to mention that other innate immune defects during Cl 13 infection, such as poor IL-12 production upon secondary MCMV infection ( Figure S4 ), may couple to the impaired IFN-I and NK cell responses to determine the early MCMV spread observed. Indeed, our failure to restore MCMV containment by the sole injection of recombinant IFNb during Cl 13 infection ( Figure S5 ) suggests multifactorial events acting in conjunction to discredit innate defense during persistent viral infection. This integrally altered innate response would facilitate early microbial spread and could potentially compromise the CD8 T cell response against secondary pathogens, which is suppressed during persistent Cl 13 infection (Tishon et al., 1993) . Notably, many other serious human opportunistic infections are sensed through TLR-9 (Bafica et al., 2005; Coban et al., 2005) , and inhibition of TLR-9 IFN-I response is likely facilitating their growth in the virally infected hosts. Our findings are in agreement with a previous report indicating that transient IFN-I exhaustion during acute infection with Semliki Forest virus (SFV) associates with enhanced susceptibility to secondary infections (Alsharifi et al., 2006) .
LCMV infection in its natural host, the mouse, has been a Rosetta Stone model to illuminate the occurrence and cause of multiple host-virus interactions in vivo (Oldstone, 2006; Zinkernagel, 2002) . The present study set the basis to use LCMV model to understand the deregulation of innate immunity during acute and chronic viral diseases. In summary, our results indicate that inhibition of systemic TLR-IFN-I production by pDCs during in vivo viral infection interferes with efficient and effective innate immune response to a subsequent infection and sets a stage for enhanced susceptibility of the host to opportunistic pathogens. Our data support the concept that an in vivo virus infection in addition to disordering adaptive immune response can also discredit the innate immune system, thus favoring microbial spread and evolution.
EXPERIMENTAL PROCEDURES Viruses
The ARM53b and Cl 13 LCMV clones were grown, identified, and quantified as described (Ahmed et al., 1984; Borrow et al., 1995; Salvato et al., 1991) . Smith strain of MCMV was obtained from Bruce Beutler, The Scripps Research Institute (TSRI). MCMV stocks were prepared from salivary glands of BALB/c mice given 1 3 10 4 PFU intraperitoneally (i.p.) (Tabeta et al., 2004) . Homogenates of pooled salivary glands were made in sterile PBS and viral titers determined by plaque assay as described (Orange et al., 1995) . New Jersey VSV strain was obtained from Dr. Robert Lamb (Northwestern University, IL) and viral titers determined on baby hamster kidney cells after 1 hr absorption at 37 C and 48 hr of 1% agarose overlay.
Mice C57BL/6 mice were obtained from the closed breeding colony of TSRI. IL-10 ko, TNF-a ko and IFN-g ko mice were obtained from Jackson Laboratory. IFNR-I ko mice were obtained from Dr. Jonathan Sprent (TSRI) and TCR ko mice were a gift from Dr. Stephen Hedrick (UCSD). All ko mice used were in C57BL/6 background. Mice at 6-8 weeks of age were infected by i.v. inoculation of LCMV (2 3 10 6 PFU either ARM or Cl 13), i. 
Cell Purification
Spleens were removed and incubated with collagenase D (1 mg/ml, Roche, Indianapolis, IN) for 20 min at 37
C. Single-cell suspension of splenocytes were enriched and purified as described previously (Zuniga et al., 2004 
Flow Cytometry
Antibodies used were either purchased from BD Pharmingen or eBioscience (San Diego, CA) to stain splenocytes: CD11b-PE-CY7, anti-CD11c-APC, anti-CD19-Percp-Cy5.5, anti-NK1.1-Percp-Cy5.5, anti-CD3-Percp-Cy5.5, anti-B220-APC-CY7, anti-B220-FITC, anti-NK1.1-PE, anti-CD69-FITC, anti-IA b -Alexa-700, and anti B7-2-PE. Anti-120G8 monoclonal antibody was kindly provided by Giorgio Trinchieri and conjugated to Alexa 488 following manufacture instructions (Molecular Probes, Invitrogen, Carlsbad, CA). Prior to staining all cell preparations were blocked with 3.3 mg/ml anti-mouse CD16/CD32 (Fc block, BD PharMingen) in PBS containing 1% FBS for 10 min. The Fc block was also included in all 20 min surface stains. Cells were acquired using the Digital LSR II flow cytometer (Becton Dickinson, San Jose, CA). Flow cytometric data were analyzed with the FlowJo software.
pDC Cultures and In Vitro Stimulation
Unless otherwise indicated, pDCs were plated at 1 3 10 5 cells/ml in 100 ml RPMI complete medium (10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, 15 mM b-mercaptoethanol). For pDC stimulation, cells were cultured overnight in the presence of HPLC purified CpG-1668 (TCCAT-GACGTTCCGATGCT phosphorothioate-modified; IDT, Inc.), CpG-2 (TCA TTG GAA AAC GTT CTT CGG GGC G phosphorothioate-modified; IDT, Inc.) at 1 mM or Loxoribine (Invivogen, San Diego, CA) at 100 mM and supernatants then collected.
Cytokine Measurements IFN-I activity was measured with reference to a recombinant mouse IFN-b standard (Research Diagnostics) using a L-929 cell line transfected with an interferon-sensitive luciferase obtained from Bruce Beutler, TSRI (Jiang et al., 2005) . Where indicated the amount of IFN-a production was determined by ELISA (PBL Biomedical, Picataway, NJ). IFN-g was quantified by ELISA (eBioscience, San Diego, CA). TNF-a, IL-12, RANTES, MCP-1, and MIP-1 a were quantified by multiplex ELISA (Quansys Biosciences, UT).
NK Cell IFN-g Production and Cytotoxicity
FACS-purified NK cells were cultured at 10 6 cells/ml for 15 hr in complete medium at 37 C in 5% CO 2 . Supernatants were harvested and stored at À70 C for IFN-g quantification by ELISA. NK cell cytotoxic activity was assessed by 51 Cr release, in a 4 hr assay at 37 C, from YAC-1 target cells, as described (Orange et al., 1995) .
Real-Time RT-PCR for Quantification of MCMV mRNA Total RNA was extracted from spleen homogenates using RNeasy kit (QIAGEN) digested with DNase I (RNase-free DNase Set, QIAGEN) and reverse transcribed into cDNA. Quantification of cDNA was performed using SYBR Green PCR Kit (Applied Byosistem) and Real-Time PCR Detection System (ABI). The relative RNA levels of Ie-1 were normalized against cellular glyceraldehydes 3-phosphate dehydrogenase (GAPDH) RNA as described (Delale et al., 2005) .
Statistical Analysis
Statistical differences were determined by Student t test or one way analysis of variance (ANOVA) with InStat 3.0 software (GraphPad, CA.). p < 0.05 were considered significant.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found online at http://www. cell.com/cellhostandmicrobe/supplemental/S1931-3128(08)00299-0.
